Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Older Adults With Asthma or COPD
NCT00162864Phase 3Completed
- Sponsor
- Kaiser Permanente
- Start
- Dec 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma and chronic obstructive pulmonary disease (COPD) comparing Montelukast with Placebo (2 arms). Primary endpoints: Forced Expiratory Volume in One Second at 6 weeks and Daytime Asthma Symptoms Scores at 6 weeks. Started Dec 1999; status: completed.
02
Drugs
montelukast
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00162864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162864.